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ABSTRACT 
Uterine fibroid, a noncancerous growth of the uterus that often appear during childbearing age of 
female and it is one such gynecological disorder which is posing a major health problem. 
Regardless of benign neoplastic character, uterine fibroids are responsible for significant 
morbidity in a large segment of the female population. Ayurvedic texts have described Mamsaja 
granthi which perfectly correlates with benign neoplasm on modern lines. The present study was 
carried out to evaluate the role of Jalakumbhi Churna in the treatment of uterine fibroid. 30 female 
patients in reproductive age group who were suffering from uterine fibroid were registered for 
the present research work. 30 patients were divided equally into 2 groups, 15 patients were 
treated with Trail group drug i.e. by Jalakumbhi churna 6gm BD for 2 months and 15 patients 
were treated with Control group drug i.e. Nagakesar churna 6gm BD for 2 months. The diagnoses 
of uterine fibroids of patients were confirmed by clinical as well as investigation findings. After 
conducting clinical trial on 30 patients, observation and results were obtained. Statistical analysis 
shows that both trail and control drug were significantly effective to reduce the cardinal 
symptoms. As compared to Control drug the effect of Trail drug is better to reduce subjective and 
objective parameters. Results shows 20% patients were cured and 80% patients were improved 
after second follow up in trial group, while 26.66% patients were improved and 73.33% patients 
were not cured after second follow up in control group. Present study concludes that trail drug 
can definitely be used as adjuvant drug in the management of uterine fibroids.  
KEYWORDS: Uterine fibroid, Mamsaja granthi, Jalakumbhi, Nagkeshar. 
INTRODUCTION
 In present times, there is steady rise in 
gynecological disorders. Among these, uterine fibroids 
have got an important place. Uterine fibroids are not 
only the commonest benign tumour of the uterus but 
are the commonest benign solid tumour in female [1]. As 
a consequence of these local pressure effects and 
bleeding, uterine fibroids rank as a major reason for 
hysterectomy accounting for approximately one-third 
of all hysterectomies or about 2,00, 000 hysterectomies 
per year. [2, 3] These are most common in nulliparous or 
in those having one child infertility. The prevalence is 
highest between 35-45 years.  
Uterine fibroids are non cancerous tumours 
consisting of fibers or fibrous tissue that arise in the 
uterus. It is the most common growth of the female 
genital tract. These tumours are highly sensitive to 
oestrogen.[4] They develop following the onset of 
menstruation, enlarge during pregnancy and decrease 
and often disappear after menopause when oestrogen 
levels are decreased by half. They can be as small as a 
hen’s egg, or commonly grow to the size of an orange or 
grapefruit. The largest fibroid on record weighed over 
100 pounds. Discovery is usually accidental, and 
coincidental with heavier period, irregular bleeding 
and or painful periods. [5]  
As uterine fibroids are seen mostly during 
prime working years, they negatively impact women’s 
ability to work. Work absence has been reported by 
40% of women. Symptoms like heavy bleeding, pain in 
abdomen, bladder irritability, etc interfere with home, 
social and work life of women due to tiredness, 
weakness, lack of control and unpredictability. 
Additionally, in women who desire pregnancy, fibroids 
cause difficulty in conception and also may increase the 
chances of abortion. [6] In Ayurvedic classics, the entity 
Granthi[7] developing in any part of the body simulates 
the description of tumour, i.e. the disease arising due to 
excessive, uncommon or peculiar and improper growth 
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of cells. Further, the disease Granthi can be equated 
with all types of small, glandular or nodular swellings 
developing mostly due to benign tumours. Specific 
description of Granthi of reproductive system is not 
available. Charak has included Granthi in the chapter 
dealing with Sotha due to similarity in basic clinical 
features.[8] He has clearly mentioned that sothas are 
situated in different body parts; these are many in 
numbers due to difference in their location, clinical 
features, names and types.[9] This clearly indicates that 
basically etiopathogenesis, clinical features and 
treatment of tumors of reproductive system are 
identical to the tumors of any other body part; 
however, few clinical features present due to specific 
location of disease had to be envisaged. Ayurvedic texts 
have described Mamsaja granthi[10] which perfectly 
correlates with benign neoplasm on modern lines. 
Keeping the above facts in mind an attempt has been 
made to find alternative drug in Ayurveda to combat 
this dreadful disease. From the different drugs 
mentioned from Ayurvedic classics Jalakumbhi (Pistia 
Stratiotus) [11] is selected for this research work. 
Aims and Objectives 
To evaluate efficacy of Jalakumbhi in the management 
of uterine fibroids.  
Materials and Methods 
30 patients of reproductive age group, 
attending the OPD and IPD of Prasooti tantra and 
Striroga department, Major S. D. Singh P. G. Ayurvedic 
Medical College & Hospital, Farrukhabad, fulfilling the 
criteria for diagnosis and selection were incorporated 
into the study. For the preparation of Jalakumbhi 
churna raw drug were purchased from the local 
markets of Farrukhabad and Kanpur district, U.P., 
India. Under the supervision of Dravyaguna specialist. 
Jalakumbhi churna was prepared in the pharmacy of 
Major S. D. Singh P. G. Ayurvedic Medical College & 
Hospital, Farrukhabad. 
Treatment Protocol 
GROUP A (Treatment group): It consists of 15 
patients who were given trial drug (churna of 
jalakumbhi) in a dose of 6 gm BD for 2 months.  
GROUP B (Control group): It consists of 15 patients 
who were given Nagkesar Churna in a dose of 6 gm BD 
for 2 months.  
Follow up  
The patients were advised to take pathya ahaar. This 
treatment protocol was continued for a period of two 
months. Patients were followed twice regularly at the 
end of each month. 
Inclusion criteria 
 Female patients of Age 25-45 years 
 Single or multiple uterine fibroids 
 Size upto 8 cms 
 Submucous fibroids  
 Intramural fibroids 
 Subperitoneal / Subserous fibroids. 
Exclusion criteria 
 Broad ligament fibroids 
 Pendunculated fibroids 
 Pregnancy 
 Systemic diseases 
 Malignant diseases 
Routine hematological investigations, USG abdomen 
pelvis and were done before and after the treatment. 
Assessment Criteria 
Subjective Parameter 
 P/V bleeding  
 Menstrual abnormalities  
 Pain in lower abdomen  
 Backache  
Objective parameter 
 Size of fibroids  
 Pads used/ day  
Patients were randomly selected from the OPD 
and IPD. A detailed history of all the cases including 
age, occupation, socio-economic status, parity, 
menstrual history and obstetrical history were 
recorded on a specially designed research care sheet.  
A physical examination of all the cases were 
carried out including general body built, height, weight, 
Dashavidha pareeksha, P/A examination, pelvic 
examination including P/S and bimanual examination 
among married women were done to rule out any 
structural abnormalities of genital organs. 
Patients were followed regularly twice one at the end 
of each month.  
Assessment Parameters 
1) Duration of blood loss  
1-5 days  - 1  
6-10 days  - 2  
11-15 days   - 3  
2) Interval of blood loss  
Normal : 28-32 days 
Frequent  : menstrual bleeding occurring at 
21 days or less 
Intermenstrual : bleeding occurring at 15-16 days 
cycle or in between 2 menstrual 
cycle 
Delayed : menstrual bleeding occurring 
more than 35 days 
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3) Amount of blood loss  
Mild : 1 
Moderate : 2 
Severe : 3 
Absent : 0 
4) No of pads/ day  
1-2 pads /day : 1 
2-3 pads/day : 2 
4-5 pads / day : 3 
5) Pain in lower abdomen  
Absent : 0 
Mild (subsides with rest only) : 1 
Moderate (subsides with medicine) : 2 
Severe (pain does not subside even by 
use of medicine) 
: 3 
6) Backache  
Present : 1 
Absent : 2 
7) Size of fibroid  
0-1 cms : 1 
1-2 cms : 2 
2-4 cms : 3 
4-6 cms : 4 
6-8 cms : 5 
Properties of Jalakumbhi (Pistia Stratiotus) [12] 
Rasa : Tikta, Madhur 
Guna : Laghu, Ruksha 
Virya : Sheeta 
Vipaka : Madhur 
Doshakarma : Tridoshashamak 
Upayogas : Jwara, Daha, Sosha, Mutrakrucha, 
Kasa, Swas, Arsha, Vibandha, Galganda, 
Twak rogas 
Chemical Analysis of Jalakumbhi (Pistia Stratiotus) 
It contains the following  
Ash – 31%  
Water – 6%  
Water contains dissoluble shar. This shar is made up of 
following:  
Potassium chloride – 73  
Potassium sulphate – 22%  
Cadmium, chromium, Cobalt, Copper, Iron, Lead, Nickel, 
Zinc, Manganese, Calcium, Sodium and Potassium, 
Selenium, Beta- carotene.  
Various studies done on Jalakumbhi show that:  
Root is emollient, laxative, and diuretic. Study on leaves 
showed presence of alkanes, flavonoids, and sterols. 
Study isolated for the first time: stigmasta-4, 22-dien-3-
one, stigmesterol, stigmasteryl state and palmitic acid. 
Pistia stratiotus leaves extract, function as an anti 
oxidant.  
Method of preparation of Jalakumbhi churna 
A dry powder, filtered through a fine cloth is 
called as churna. According to Acharya Sarangadhara, 
Churna is a fine powder of completely dried drug which 
is filtered through cloth. The drug, taken in completely 
dry form is pounded well in Ulukhala yantra and sieved 
through different sized sieves. 
Shelf life  
6 months. (2 months according to Sarangdhar). 
Follow-up study 
Patients were followed regularly twice, at the end of 
each month. 
Observations and Results  
The present study was carried out in total 30 
patients in two groups as prospective study by simple 
randomized method of selection. The patients were 
tested in this clinical trial for drug efficacy. To evaluate 
the effect of trial treatment on uterine fibroid, the 
data’s were collected and analyzed on the basis of:  
1. Demographic findings  
2. Patient clinical findings  
3. Statistical analysis of subjective & objective 
parameters.  
The following observations were made during the 
course of the present clinical research. 
Table 1: Demographic Observations 
Geographic observation Predominance Percentage No. of patients 
Age 36-40 yrs 43.33% 13 
Age of Menarche 11-14 yrs 83.33% 25 
Socio-economic status  Middle class 63.33% 19 
Marital Status  Married 70% 21 
Parity 1 child and No child 36.66% 11 
Educational Status Literate 73.33% 22 
Occupational Status Professional 50% 15 
Diet Mixed  67% 20 
Mental status Stressed  73.33% 22 
Prakruti (nature of patient) Kaphaja 50% 15 
Family history Not Present  83% 25 
Habitat  Anupa  67% 20 
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Table 2: Comparison of Results of Parameters in both Groups at 2nd Follow up 
Parameter  Mean BT-
AT of A  
Mean BT-
AT of B  
Mean  
Difference  
SD  SEM  t  P  Remarks  
Duration of Blood Loss  1.33  0.7 0.63  0.54  0.19 3.2  <0.01  Significant  
Interval of Blood Loss  0.6  0.73 0.13  0.66  0.23  0.54  <0.10  Not Significant  
Amount of Blood Loss  1.46  0.86  0.6  0.58  0.2 2.91  <0.01  Significant  
No of Pads  1.33  0.6  0.73  0.67  0.24  3.04  <0.01  Significant  
Pain in Lower Abdomen  3.13  0.53  2.6  0.56  0.2 12.93  <0.001  Highly Significant  
Backache  1 0.13  0.87  0.52  0.18  4.6  <0.01  Significant  
Size of Fibroid  1.13  0  1.13  0.06  0.02  53.95  <0.001  Highly Significant  
Table 3: Overall Effect of Treatment 
 Trail group   Control group  
   AT1  AT2 AT1 AT2 
Improvement No of Pts % No of Pts % No of pts  %  No of Pts  %  
Cured (67-100%)  0 0 3 20.0 0 0 0 0 
Improved (34-66%) 5 29.4 12 80.0 1 6.6 4 26.6 
Not cured (0-33%)  10 70.5 0 0 14 93.3 11 73.3 
 
In the present study overall effect of treatment 
showed that, in trial group after first follow up 29.45% 
improved and 70.55% patients have no change while in 
placebo group after first follow up 6.67% patients 
improved and 93.33% patients have no change. After 
second follow up 20% patients were cured and 80% 
were improved in trial group and in placebo group 
26.66% patients improved and 73.33% were cured. 
 DISCUSSION 
The work undertaken for the present study is 
Uterine Fibroid. Even though the modern treatment has 
developed rapidly still present generation is switching 
towards Ayurveda which offers better solutions, at this 
juncture an attempt has been made to provide a better 
assistance for this painful disorder. While searching the 
literature one finds that Uterine fibroid is the nearest 
clinical correlation of Mamsaja granthi. Sushruta has 
described Granthi, Apachi, Gandamala in Nidana as well 
as in Chikitsa Sthana.[13] Granthi description appears to 
be containing few of the benign conditions. It is caused 
because of Dushti of Tridosha, Mamsa, Meda and Rakta 
dhatus that manifests as round, raised, nodular 
swelling. The present clinical study entitled “Role of 
Jalakumbhi in Uterine fibroid” was aimed to evaluate 
the role of Jalakumbhi on uterine fibroids. In the 
present clinical study 15 cases had been treated with 
trial drug after being diagnosed with uterine fibroids. 
The observations were made on the different 
parameters including clinical findings. The incidental 
study like age of patients, marital status, and age of 
menarche, parity, socio-economic status, Prakruti, 
family history and diet of patients were carried out. 
And even incidence according to symptomatology 
study was carried out which has been shown by table 1 
& 2, where the improvement in Duration of blood loss 
in trial group was 57.08% while in placebo group it was 
28.85% after the second follow up is seen, Interval of 
blood loss in trial group was 37.50% while in placebo 
group it was 37% after the second follow up is seen, 
Amount of blood loss in trial group was 50.10% while 
in placebo group it was 31.07% after the second follow 
up is seen, Number of pads in trial group was 45.39% 
while in placebo group it was 20.97% after the second 
follow up is seen, Pain in lower abdomen in trial group 
was 65% while in placebo group it was 20.94% after 
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the second follow up is seen, Backache in trial group 
was 44.32% while in placebo group it was 6.1% after 
the second follow up is seen, Size of fibroid in trial 
group was 44.66% while in placebo group it was 0% 
after the second follow up is seen. Overall effect of 
therapy in the present study shows that Jalakumbhi 
helps in reducing the symptoms, and trial group is 
more effective than control group (Table: 3). The 
results are encouraging though percentage of the 
patient was 20% to get cured from uterine fibroid. 
Probable mode of action of drug 
In the manifestation of Granthi there is 
vitiation of Tridosha, which vitiates the Dushya rakta, 
Mamsa and Medas, impairment of Agni (due to Ama) 
and causes suppression of Vyadhi kshamata and Sroto 
vaigunya. Jalakumbhi according to its Doshakarma, is 
Tridosha shamaka. In Susruta Samhita Chikitsa 1/10 the 
treatment of Granthi is described same as that of 
Sopha[14]. For Sopha, the line of treatment is Virechan. 
Again, Granthi comes under Virechan yogya vyadhis. 
The Karma of Jalakumbhi is Mrudu virechan and 
Anulomana. Due to its detoxification action by Virechan 
karma Jalakumbhi acts on fibroid. According to studies, 
Jalakumbhi consists of flavonoids. Flavonoids have got 
anti oestrogenic action which helps to cure fibroids that 
are caused because of hyper oestrogenic state. Again, 
for the treatment of fibroids, antioxidants play an 
important role. Jalakumbhi consists of following 
antioxidants, Betacarotene[15], Selenium and Zinc. 
CONCLUSION  
Oral administration of Jalakumbhi churna for 
two months helped nearly 20% patients of female in 
uterine fibroid to get cured. No adverse side effects 
were observed during and after treatment. The results 
are encouraging but rate of cured patients is low. Hence 
it is suggested to plan further study by giving the drug 
in other modality of administration and should be 
carried out on a large scale so that satisfactory results 
are obtained. 
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